Our data suggest that preserving and restoring AM numbers early during infection, such as through nebulized delivery of GM-CSF, may be a valid therapeutic strategy to protect airway integrity and to initiate an early innate and adaptive immune response (44). This evidence concerns the gene CSF2 and infection.